
Patients undergoing anti-cancer treatment that incorporates intravenous and oral agents may experience compound adverse effects and challenges related to treatment adherence. Through a national mixed-methods study, ACCC is assessing how care coordination may be improved for these patients. Read more from Oncology Nurse Advisor.
Posted 10/21/2022

To better reach its patients living in rural communities throughout Georgia with targeted interventions, 2026 ACCC Innovator Award winner Winship Cancer Institute developed an Embedded Community Staff model, which leverages the experiential knowledge of local community members.

2026 ACCC Innovator Award Winner UNC Lineberger Comprehensive Cancer Center noticed a common pain point among patients who received oncolytic virus treatment for advanced melanoma: time spent in appointments. To minimize the need for multiple lengthy appointments, the center developed a pharmacist-led strategy that utilized virtual visits and premixing doses prior to in-person visits.

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.
